Lobbying Information
Subject Matters
- Aboriginal Affairs
- Budget
- Economic Development
- Federal-Provincial Relations
- Health
- Industry
- Intellectual Property
- International Trade
- Research and Development
- Science and Technology
- Taxation and Finance
Subject Matter Details
Legislative Proposal, Bill or Resolution, Policies or Program, Regulation
- Communications regarding national pharmacare legislation, regulations, policies or programs.
Policies or Program
- Communications regarding access to and approval of medicines addressing the growing public health threat of antimicrobial resistance.
- Communications regarding the design and implementation of the federal Drugs for Rare Diseases strategy.
- Communications regarding the value assessment of new medicines by the Canadian Drug Agency (CDA) and the design of proposed new work streams, insofar as the federal government is a funder and holds a seat on the Board of Directors.
- Communications with Health Canada regarding guidelines for pediatric action plans.
- Communications with Health Canada regarding the application of its nitrosamine guidelines.
- Engagement with Health Canada’s Regulatory Operations & Enforcement branch regarding supply chain resilience & integrity; mitigating and alleviating drug shortages.
- Federal Government Non Insured Health Benefits program with respect to reimbursement of a prescription medicine and changes in type of reimbursement
- Innovation, Science and Economic Development (ISED)'s Biomanufacturing and Life Sciences Strategy, pertaining to growth and development of the life sciences industry in Canada.
- Patented Medicine Prices Review Board (PMPRB) Guidelines with regard to prices charged by Rights Holders for patented medicines sold in Canada.
- Public Health Agency of Canada, regarding the federal response to the hepatitis C virus.
- The pan Canadian Pharmaceutical Alliance (pCPA) with respect to public formulary listing of new medicines, insofar as the federal government is a participating jurisdiction and holds a seat on the Board of Directors.
Policies or Program, Regulation
- Communications regarding Health Canada's Regulatory Innovation Agenda regarding proposed regulatory amendments and guidelines to enable agile licensing of drugs and medical devices.
- Communications regarding intellectual property protection of prescription drugs, including the Patent Act, the Patented Medicines Regulations, the Patented Medicine Notice of Compliance (PMNOC) Regulations, the Patent Term Adjustment regime and Health Canada’s Data Protection regime.
- Communications with Health Canada regarding modernization of clinical trials regulations, including diversity and inclusivity of clinical trials.
- Communications with Health Canada regarding the evolution of the regulatory framework to address advanced therapeutic products.
- Communications with Heath Canada regarding modernization of the medical devices regulatory framework.
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Atlantic Canada Opportunities Agency (ACOA)
-
Canadian Institutes of Health Research (CIHR)
-
Correctional Service of Canada (CSC)
-
Employment and Social Development Canada (ESDC)
-
Finance Canada (FIN)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Immigration and Refugee Board (IRB)
-
Indigenous Services Canada (ISC)
-
Innovation, Science and Economic Development Canada (ISED)
-
Intergovernmental Affairs Secretariat (IGA)
-
Invest in Canada Hub
-
National Defence (DND)
-
National Research Council (NRC)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Health Agency of Canada (PHAC)
-
Public Services and Procurement Canada (PSPC)
-
Royal Canadian Mounted Police (RCMP)
-
Senate of Canada
-
Treasury Board Of Canada Secretariat (TBS)
-
Veterans Affairs Canada (VAC)
In-house Corporation Details
Description of activities
AbbVie is a global, research-based biopharmaceutical company formed in 2013. We use our expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.
Responsible officer name and position during the period of this registration
RAMI FAYED,
Vice President and General Manager, Canada
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
8401 Transcanada Highway
St-Laurent, QC H4S 1Z1
Canada
Telephone number:
888-703-3006
Parent Company Information
- AbbVie
-
100 Abbott Park Rd
Abbott Park, IL 60064-3500
United States of America
Subsidiary Beneficiary Information
AbbVie Corporation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Stephane Barakat,
Head, Market Access & HEOR, Oncology |
No public offices held
- Christine Eleia,
Head, Market Access & HEOR, Immunology |
No public offices held
- Caroline Jacques,
Senior Counsel, Canada |
No public offices held
- Thula Kanagenthiran,
Head, Market Access & HEOR, Specialty |
No public offices held
- Corry McElrea,
Head, Field Market Access & Government Affairs |
No public offices held
- Amber McLeod,
Lead, Regulatory Affairs |
No public offices held
- Judith Mergl,
Director, Regulatory Affairs |
No public offices held
- Steve Popp,
Head, Strategic Pricing & Contracting |
No public offices held
- Arima Ventin,
Executive Director, Market Access and Government Affairs |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Sara Chahab,
Field Lead, Market Access & Government Affairs - Immunology |
No public offices held
- Adam Cook,
Manager, Market Access and Government Affairs, Ontario & Federal Programs |
No public offices held
- Catherine Desjardins,
Field Lead, Market Access & Government Affairs - Oncology |
No public offices held
- Lauren Fischer,
Lead, Government Affairs & Policy |
No public offices held
- Harold Just,
Manager, Market Access and Government Affairs - Oncology |
No public offices held
- David Link,
Field Lead, Market Access & Government Affairs - Specialty |
No public offices held
- Claude Longpre,
Manager, Government Affairs, Quebec |
No public offices held
- Eric Pegolo,
Manager, Market Access and Government Affairs, Ontario |
No public offices held
